US 8263549
C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors
granted A61KA61K38/00A61P
Quick answer
US patent 8263549 (C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12